The market forecast envisions a 6.8% CAGR through 2033, propelled by rising minimally invasive volumes, outpatient migration, and robotics programs that demand real-time navigation. Technology shifts toward flat-panel detectors, photon-counting CT, and AI-powered image fusion are compressing scan times while insurers tighten reimbursement for revision surgeries, incentivizing hospitals to invest in high-confidence guidance tools. Competitive intensity is sharpening as Medtronic, Siemens Healthineers, and GE Healthcare expand leasing and pay-per-use models, alleviating capital-budget friction and shortening replacement cycles. Regionally, North America commands the largest share on the back of ASC conversions and high robotics penetration, whereas Asia-Pacific is projected to be the fastest-expanding region, underpinned by China’s 1,000-hospital “5G + remote surgery” initiative and India’s 200 new tertiary cancer centers. Supply-chain vigilance around helium and semiconductor components remains the critical watch-point for strategic planners mapping capacity through 2030.